Patent ID: 9717729
Date: 2017-08-01
CPC Classifications: A61K,A61P,C07D

Claim:
1. A method of treating or preventing a disease or condition selected from the group consisting of macular degeneration, diabetic retinopathy (DR), macular edema, diabetic macular edema (DME), and macular edema following retinal vein occlusion (RVO) in a subject, comprising administering to a subject in need thereof a therapeutically effective amount of a compound of formula I: or a pharmaceutically acceptable salt or solvate thereof, wherein: Z is R and R′ are each independently H or F, or R and R′, together with the carbon atom to which they are attached, form a 3- or 4-membered carbocyclic or heterocyclic ring; Q is X is CH or N; Y is CH or N; R R provided that the compound of formula I contains at least one fluorine atom.